• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病基因大鼠模型的新进展。

New Developments in Genetic rat models of Parkinson's Disease.

机构信息

Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

出版信息

Mov Disord. 2018 May;33(5):717-729. doi: 10.1002/mds.27296. Epub 2018 Feb 8.

DOI:10.1002/mds.27296
PMID:29418019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5992003/
Abstract

Preclinical research on Parkinson's disease has relied heavily on mouse and rat animal models. Initially, PD animal models were generated primarily by chemical neurotoxins that induce acute loss of dopaminergic neurons in the substantia nigra. On the discovery of genetic mutations causally linked to PD, mice were used more than rats to generate laboratory animals bearing PD-linked mutations because mutagenesis was more difficult in rats. Recent advances in technology for mammalian genome engineering and optimization of viral expression vectors have increased the use of genetic rat models of PD. Emerging research tools include "knockout" rats with disruption of genes in which mutations have been causally linked to PD, including LRRK2, α-synuclein, Parkin, PINK1, and DJ-1. Rats have also been increasingly used for transgenic and viral-mediated overexpression of genes relevant to PD, particularly α-synuclein. It may not be realistic to obtain a single animal model that completely reproduces every feature of a human disease as complex as PD. Nevertheless, compared with mice with the same mutations, many genetic rat animal models of PD better reproduce key aspects of PD including progressive loss of dopaminergic neurons in the substantia nigra, locomotor behavior deficits, and age-dependent formation of abnormal α-synuclein protein aggregates. Here we briefly review new developments in genetic rat models of PD that may have greater potential for identifying underlying mechanisms, for discovering novel therapeutic targets, and for developing greatly needed treatments to slow or halt disease progression. © 2018 International Parkinson and Movement Disorder Society.

摘要

帕金森病的临床前研究主要依赖于小鼠和大鼠动物模型。最初,PD 动物模型主要通过化学神经毒素产生,这些毒素诱导黑质中多巴胺能神经元的急性丧失。在发现与 PD 有因果关系的遗传突变后,更多地使用小鼠而不是大鼠来生成携带 PD 相关突变的实验动物,因为大鼠中的诱变更为困难。哺乳动物基因组工程技术的最新进展和病毒表达载体的优化增加了 PD 遗传大鼠模型的使用。新兴的研究工具包括基因敲除大鼠,这些大鼠中的基因发生了突变,与 PD 有因果关系,包括 LRRK2、α-突触核蛋白、Parkin、PINK1 和 DJ-1。大鼠也越来越多地用于与 PD 相关的转基因和病毒介导的基因过表达,特别是 α-突触核蛋白。获得一个能够完全复制 PD 等复杂人类疾病的所有特征的单一动物模型可能并不现实。然而,与具有相同突变的小鼠相比,许多 PD 的遗传大鼠动物模型更好地复制了 PD 的关键方面,包括黑质中多巴胺能神经元的进行性丧失、运动行为缺陷以及年龄依赖性形成异常的 α-突触核蛋白蛋白聚集体。在这里,我们简要回顾了 PD 的遗传大鼠模型的新进展,这些进展可能具有更大的潜力来确定潜在的机制、发现新的治疗靶点,并开发急需的治疗方法来减缓或阻止疾病进展。 © 2018 国际帕金森病和运动障碍协会。

相似文献

1
New Developments in Genetic rat models of Parkinson's Disease.帕金森病基因大鼠模型的新进展。
Mov Disord. 2018 May;33(5):717-729. doi: 10.1002/mds.27296. Epub 2018 Feb 8.
2
Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.线粒体动力学和功能受损在帕金森病发病机制中的作用
Exp Neurol. 2009 Aug;218(2):235-46. doi: 10.1016/j.expneurol.2009.03.006. Epub 2009 Mar 18.
3
Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum.帕金森病相关基因敲除大鼠纹状体的基础和诱发性神经递质水平。
Neuroscience. 2019 Jun 15;409:169-179. doi: 10.1016/j.neuroscience.2019.04.033. Epub 2019 Apr 25.
4
Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.LRRK2、SNCA、Parkin、PINK1 和 DJ-1 在赞比亚帕金森病患者中的分析。
Parkinsonism Relat Disord. 2012 Jun;18(5):567-71. doi: 10.1016/j.parkreldis.2012.02.018. Epub 2012 Mar 24.
5
Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.帕金森病相关基因突变小鼠的行为和神经化学增强令人惊讶。
Neurobiol Dis. 2014 Feb;62:113-23. doi: 10.1016/j.nbd.2013.09.009. Epub 2013 Sep 26.
6
Use of viral vectors to create animal models for Parkinson's disease.利用病毒载体创建帕金森病动物模型。
Neurobiol Dis. 2012 Nov;48(2):189-201. doi: 10.1016/j.nbd.2011.12.038. Epub 2011 Dec 29.
7
What genetics tells us about the causes and mechanisms of Parkinson's disease.遗传学告诉我们帕金森病的病因和发病机制。
Physiol Rev. 2011 Oct;91(4):1161-218. doi: 10.1152/physrev.00022.2010.
8
α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.α-突触核蛋白的单拷贝转基因表达增加了对帕金森病遗传模型中应激的敏感性并加速了神经元的丢失。
Exp Neurol. 2018 Dec;310:58-69. doi: 10.1016/j.expneurol.2018.09.001. Epub 2018 Sep 5.
9
Parkinson's disease.帕金森病。
Hum Mol Genet. 2007 Oct 15;16 Spec No. 2:R183-94. doi: 10.1093/hmg/ddm159.
10
Curcumin exposure induces expression of the Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells.姜黄素暴露诱导帕金森病相关富亮氨酸重复激酶 2(LRRK2)在大鼠中脑细胞中的表达。
Neurosci Lett. 2010 Jan 4;468(2):120-4. doi: 10.1016/j.neulet.2009.10.081. Epub 2009 Oct 30.

引用本文的文献

1
Epigenetic regulation of the respiratory chain by a mitochondrial distress-related redox signal.线粒体应激相关氧化还原信号对呼吸链的表观遗传调控。
Front Cell Dev Biol. 2025 Aug 5;13:1608400. doi: 10.3389/fcell.2025.1608400. eCollection 2025.
2
The Mitochondrial Foundations of Parkinson's Disease: Therapeutic Implications.帕金森病的线粒体基础:治疗意义
Aging Dis. 2025 Apr 28;16(5):2695-2720. doi: 10.14336/AD.2025.0440.
3
Protocols for Metabolomic Analyses to Assess Changes in Central Carbon Metabolism from Neural Tissue.

本文引用的文献

1
Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.不同的 α-突触核蛋白菌株及其对 α-突触核蛋白病异质性的影响。
Neurobiol Dis. 2018 Jan;109(Pt B):209-218. doi: 10.1016/j.nbd.2017.07.018. Epub 2017 Jul 24.
2
Animal models of α-synucleinopathy for Parkinson disease drug development.用于帕金森病药物开发的α-突触核蛋白病动物模型。
Nat Rev Neurosci. 2017 Sep;18(9):515-529. doi: 10.1038/nrn.2017.75. Epub 2017 Jul 13.
3
α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration.
用于评估神经组织中中心碳代谢变化的代谢组学分析方案。
Methods Mol Biol. 2025;2925:329-382. doi: 10.1007/978-1-0716-4534-5_24.
4
Dopamine D2 receptor upregulation in dorsal striatum in the LRRK2-R1441C rat model of early Parkinson's disease revealed by in vivo PET imaging.体内PET成像揭示早期帕金森病LRRK2-R1441C大鼠模型背侧纹状体中多巴胺D2受体上调
Sci Rep. 2025 May 7;15(1):15943. doi: 10.1038/s41598-025-99580-x.
5
Animals as Architects: Building the Future of Technology-Supported Rehabilitation with Biomimetic Principles.动物作为建筑师:运用仿生原理构建技术支持康复的未来。
Biomimetics (Basel). 2024 Nov 22;9(12):723. doi: 10.3390/biomimetics9120723.
6
Liquid-liquid phase separation and conformational strains of -Synuclein: implications for Parkinson's disease pathogenesis.α-突触核蛋白的液-液相分离和构象应变:对帕金森病发病机制的影响
Front Mol Neurosci. 2024 Oct 23;17:1494218. doi: 10.3389/fnmol.2024.1494218. eCollection 2024.
7
Cerebellar activity in PINK1 knockout rats during volitional gait.PINK1基因敲除大鼠在自主步态过程中的小脑活动。
Brain Commun. 2024 Oct 25;6(5):fcae249. doi: 10.1093/braincomms/fcae249. eCollection 2024.
8
Modeling of Parkinson's Disease in Different Models.不同模型中帕金森病的建模
CNS Neurol Disord Drug Targets. 2025;24(2):102-114. doi: 10.2174/0118715273326866240922193029.
9
Aging, Parkinson's Disease, and Models: What Are the Challenges?衰老、帕金森病与模型:面临哪些挑战?
Aging Biol. 2023;1. doi: 10.59368/agingbio.20230010. Epub 2023 Jul 28.
10
F-DOPA PET imaging identifies a dopaminergic deficit in a rat model with a G51D α-synuclein mutation.F-DOPA正电子发射断层扫描成像在具有G51D α-突触核蛋白突变的大鼠模型中识别出多巴胺能缺陷。
Front Neurosci. 2023 May 24;17:1095761. doi: 10.3389/fnins.2023.1095761. eCollection 2023.
α-突触核蛋白原纤维诱导的包涵体在大鼠和小鼠中的扩散与多巴胺能神经退行性变相关。
Neurobiol Dis. 2017 Sep;105:84-98. doi: 10.1016/j.nbd.2017.05.014. Epub 2017 May 30.
4
Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation.富含亮氨酸重复激酶2(LRRK2)依赖性神经退行性变的机制:酶活性和蛋白质聚集的作用
Biochem Soc Trans. 2017 Feb 8;45(1):163-172. doi: 10.1042/BST20160264.
5
LRRK2 mouse models: dissecting the behavior, striatal neurochemistry and neurophysiology of PD pathogenesis.LRRK2小鼠模型:剖析帕金森病发病机制中的行为、纹状体神经化学和神经生理学
Biochem Soc Trans. 2017 Feb 8;45(1):113-122. doi: 10.1042/BST20160238.
6
Toxic effects of human and rodent variants of alpha-synuclein in vivo.体内人源和啮齿动物源α-突触核蛋白变体的毒性作用。
Eur J Neurosci. 2017 Feb;45(4):536-547. doi: 10.1111/ejn.13493. Epub 2017 Jan 11.
7
First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers.抗α-突触核蛋白单克隆抗体PRX002在健康志愿者中的首次人体评估。
Mov Disord. 2017 Feb;32(2):211-218. doi: 10.1002/mds.26878. Epub 2016 Nov 25.
8
Functional alterations of the dopaminergic and glutamatergic systems in spontaneous α-synuclein overexpressing rats.自发性过表达α-突触核蛋白大鼠中多巴胺能和谷氨酸能系统的功能改变
Exp Neurol. 2017 Jan;287(Pt 1):21-33. doi: 10.1016/j.expneurol.2016.10.009. Epub 2016 Oct 20.
9
SWATH-MS proteome profiling data comparison of DJ-1, Parkin, and PINK1 knockout rat striatal mitochondria.DJ-1、Parkin和PINK1基因敲除大鼠纹状体线粒体的SWATH-MS蛋白质组分析数据比较
Data Brief. 2016 Sep 23;9:589-593. doi: 10.1016/j.dib.2016.09.031. eCollection 2016 Dec.
10
A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease.一种靶向α-突触核蛋白的新型化合物可改善帕金森病模型中的缺陷。
Brain. 2016 Dec;139(Pt 12):3217-3236. doi: 10.1093/brain/aww238. Epub 2016 Sep 27.